William A. Waldegrave is Director at GW PHARMACEUTICALS PLC (GWPH). They have made 1 open-market trade across 1 company since 2019, most recently 2019-07-10.
CIK 0001754145
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GWPH | 3,576 | $783K |
Shares reported on the most recent Form 4, priced at the 2019-07-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GWPH | SELL | 2019-07-10 | 2019-07-11 | $15.00 | $54K | -7.1% | -8.2% | -36.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.